4.7 Review

Chronic Inflammation in Obesity and Cancer Cachexia

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/jcm11082191

Keywords

chronic inflammation; obesity; cachexia

Ask authors/readers for more resources

Chronic inflammation is associated with obesity, metabolic diseases, and increased cancer risk. Elevated levels of pro-inflammatory cytokines, such as adipocytokines, are found in chronic metabolic diseases. Cytokines and inflammatory mediators play a significant role in tumorigenesis. Cachexia is linked to a dysregulation of metabolic pathways.
Chronic inflammation has long been linked to obesity and related conditions such as type 2 diabetes and metabolic syndrome. According to current research, the increased risk of cancer in people with certain metabolic diseases may be due to chronic inflammation. Adipocytokines, which are pro-inflammatory cytokines secreted in excess, are elevated in many chronic metabolic diseases. Cytokines and inflammatory mediators, which are not directly linked to DNA, are important in tumorigenesis. Cachexia, a type of metabolic syndrome linked to the disease, is associated with a dysregulation of metabolic pathways. Obesity and cachexia have distinct metabolic characteristics, such as insulin resistance, increased lipolysis, elevated free fatty acids (FFA), and ceramide levels, which are discussed in this section. The goal of this research project is to create a framework for bringing together our knowledge of inflammation-mediated insulin resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Plant Sciences

Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L.

Davide Gnocchi, Gianluigi Cesari, Generosa Jenny Calabrese, Roberto Capone, Carlo Sabba, Antonio Mazzocca

PLANT FOODS FOR HUMAN NUTRITION (2020)

Article Biochemistry & Molecular Biology

A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells

Rosa Lippolis, Davide Gnocchi, Luigi Santacroce, Rosa Anna Siciliano, Maria Fiorella Mazzeo, Salvatore Scacco, Carlo Sabba, Antonio Mazzocca

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Oncology

The perplexity of targeting genetic alterations in hepatocellular carcinoma

Michele Barone, Alfredo Di Leo, Carlo Sabba, Antonio Mazzocca

MEDICAL ONCOLOGY (2020)

Article Oncology

DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer

Matteo Lulli, Laura Del Coco, Tommaso Mello, Caecilia Sukowati, Stefania Madiai, Laura Gragnani, Paolo Forte, Francesco Paolo Fanizzi, Antonio Mazzocca, Krista Rombouts, Andrea Galli, Vinicio Carloni

Summary: This study reveals that CHK2, a central effector of DNA damage response, regulates cellular energy production by affecting glycolysis and mitochondrial functions. Patients with hepatocellular carcinoma (HCC) showed increased CHK2 mRNA levels in blood, which correlated with elevated TCA metabolites, indicating the role of CHK2 in controlling mitochondrial functions.

CANCER RESEARCH (2021)

Article Chemistry, Medicinal

Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth

Davide Gnocchi, Maria M. Cavalluzzi, Giuseppe F. Mangiatordi, Rosanna Rizzi, Cosimo Tortorella, Mauro Spennacchio, Giovanni Lentini, Angela Altomare, Carlo Sabba, Antonio Mazzocca

Summary: Novel XAA derivatives were synthesized and characterized, showing improved inhibitory effects on HCC growth by increasing alkyl group length. Experimental results indicated that compound MC11 exhibited the strongest anti-HCC activity among the derivatives.

CHEMMEDCHEM (2021)

Article Health Care Sciences & Services

Body Composition Change, Unhealthy Lifestyles and Steroid Treatment as Predictor of Metabolic Risk in Non-Hodgkin's Lymphoma Survivors

A. Daniele, A. Guarini, S. De Summa, M. Dellino, G. Lerario, S. Ciavarella, P. Ditonno, A. V. Paradiso, R. Divella, P. Casamassima, E. Savino, M. D. Carbonara, C. Minoia

Summary: Unhealthy lifestyles and changes in body composition among non-Hodgkin's lymphoma survivors may increase the risk of metabolic syndrome and sarcopenia. Early nutritional intervention, along with adequate physical activity and healthier lifestyle, should be recommended during follow-up to reduce the risk of MetSyn onset and associated diseases in the long term.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Biochemistry & Molecular Biology

Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma

Davide Gnocchi, Agata Kurzyk, Antonella Mintrone, Giovanni Lentini, Carlo Sabba, Antonio Mazzocca

Summary: Hepatocellular carcinoma (HCC) is a highly threatening tumor, and the current pharmacological treatments for HCC rely on protein kinase inhibitors. However, these approaches often result in side effects and drug resistance. This study reveals that LPAR6-mediated metabolic mechanism contributes to sorafenib resistance in HCC and proposes a pharmacological approach to overcome it.

BIOCHIMIE (2022)

Article Biochemistry & Molecular Biology

Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance

Davide Gnocchi, Carlo Sabb, Antonio Mazzocca

Summary: After decades of research on tumour genetics, the importance of metabolism in tumour biology is being emphasized again. Cancer cells undergo metabolic rewiring, switching from oxidative phosphorylation (OXPHOS) to lactic acid fermentation, known as the Warburg effect. However, the role of this metabolic transition in cancer drug resistance remains unclear.

BIOCHIMIE (2023)

Review Biochemistry & Molecular Biology

The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance

Vinicio Carloni, Elisa Morganti, Andrea Galli, Antonio Mazzocca

Summary: Variation in chromosome structure is a major indicator of chromosomal instability, causing DNA damage and activating the DNA damage response. Cancer cells can use these mechanisms as an evolutionary mechanism to develop new functional assets under therapeutic pressure. Understanding the vulnerabilities in DNA damage response, chromatin changes, and inflammation can help predict treatment response and prevent the emergence of therapy resistant tumors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy

Davide Gnocchi, Carlo Sabba, Mara Massimi, Antonio Mazzocca

Summary: Despite the decrease in chronic hepatitis infections, hepatocellular carcinoma remains a major cause of cancer-related death worldwide, largely due to the rise in metabolic diseases. Current aggressive protein kinase inhibitor therapies in HCC are not curative, thus a shift towards metabolic therapies may offer a promising option.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice

Davide Gnocchi, Marta B. Afonso, Maria Maddalena Cavalluzzi, Giovanni Lentini, Giuseppe Ingravallo, Carlo Sabba, Cecilia M. P. Rodrigues, Antonio Mazzocca

Summary: Hepatocellular carcinoma (HCC) is a concerning and increasingly prevalent tumor. Traditional pharmacological approaches have limitations and side effects, necessitating the development of new molecules. This study shows that LPAR6 plays a role in CDAA diet-induced HCC in mice, and XAA can counteract diet-induced effects on liver health. These findings are supported by experiments in HCC cells with altered LPAR6 function.

MOLECULAR CARCINOGENESIS (2023)

Review Nutrition & Dietetics

The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer

Rosa Divella, Graziella Marino, Stefania Infusino, Laura Lanotte, Gaia Gadaleta-Caldarola, Gennaro Gadaleta-Caldarola

Summary: A healthy diet and regular physical activity are effective ways to prevent and manage diseases, including cancer. Maintaining a normal body weight through exercise helps to avoid the risk of cancer. Regular physical activity not only helps maintain a normal body weight, but also strengthens the immune system and prevents cardiovascular and metabolic diseases. The combination of a healthy diet and exercise can improve the expectations and quality of life of cancer patients.

NUTRIENTS (2023)

Article Oncology

The Role of Circulating Adiponectin and SNP276G>T at ADIPOQ Gene in BRCA-mutant Women

Antonella Daniele, Angelo Virgilio Paradiso, Rosa Divella, Maria Digennaro, Margherita Patruno, Stefania Tommasi, Brunella Pilato, Antonio Tufaro, Michele Barone, Carla Minoia, Donatella Colangelo, Eufemia Savino, Porzia Casamassima, Eleonora Bruno, Andreina Oliverio, Patrizia Pasanisi

CANCER GENOMICS & PROTEOMICS (2020)

No Data Available